Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
25.65
-0.04 (-0.16%)
Jul 1, 2026, 9:30 AM EDT - Market open
THNR Holdings Information
THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Novo Nordisk stock at 9.91%, Eli Lilly and Company at 9.45%, Scholar Rock Holding at 5.76%, Hims & Hers Health at 5.53%, and Viking Therapeutics at 5.43%.
Total Holdings
23
Top 10 Percentage
61.39%
Asset Class
Equity
ETF Category
Health
Assets
4.14M
PE Ratio
17.19
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 9.91% |
| 2 | LLY | Eli Lilly and Company | 9.45% |
| 3 | SRRK | Scholar Rock Holding Corporation | 5.76% |
| 4 | HIMS | Hims & Hers Health, Inc. | 5.53% |
| 5 | VKTX | Viking Therapeutics, Inc. | 5.43% |
| 6 | ABBV | AbbVie Inc. | 5.30% |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | 5.01% |
| 8 | MRK | Merck & Co., Inc. | 5.01% |
| 9 | LON: AZN | AstraZeneca PLC | 5.00% |
| 10 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.99% |
| 11 | SWX: ROP | Roche Holding AG | 4.95% |
| 12 | AMGN | Amgen Inc. | 4.90% |
| 13 | HKG: 1801 | Innovent Biologics, Inc. | 4.78% |
| 14 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 4.59% |
| 15 | PFE | Pfizer Inc. | 4.49% |
| 16 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.36% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 3.46% |
| 18 | KLRA | Kailera Therapeutics, Inc. | 2.35% |
| 19 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.10% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 1.89% |
| 21 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class | 0.54% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.20% |
| 23 | n/a | JAPANESE YEN | 0.00% |
As of Jun 26, 2026